# Trade Mark Journal No.2026/021 22 May 2026

## WO0000001916462 (5)

Office of origin: United States of America

Date of International Registration:14 April 2026
Date of designation in the UK: 14 April 2026

International priority date claimed: 17 October 2025 (United States of America) (99449790)

Class 5
  Pharmaceutical preparations for the treatment of pulmonary diseases and disorders; pharmaceutical preparations for the treatment of lung diseases and disorders; pharmaceutical preparations for the treatment of interstitial lung disease.

aTyr Pharma, Inc.

Representative: Brendan J. Hughes Cooley LLP, 1299 Pennsylvania Avenue, NW, Suite 700,, ATTN: IP Docketing Department, Washington DC 20004-2400, UNITED STATES OF AMERICA